IPHA Annual EBIT
-$7.50 M
+$53.33 M+87.67%
31 December 2023
Summary:
As of January 23, 2025, IPHA annual earnings before interest & taxes is -$7.50 million, with the most recent change of +$53.33 million (+87.67%) on December 31, 2023. During the last 3 years, it has fallen by -$6.95 million (-1246.22%). IPHA annual EBIT is now -151.88% below its all-time high of $64.31 million.IPHA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Quarterly EBIT
N/A
30 June 2024
Summary:
IPHA quarterly earnings before interest & taxes is not available.IPHA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA TTM EBIT
N/A
30 June 2024
Summary:
IPHA TTM earnings before interest & taxes is not available.IPHA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.7% | - | - |
| 3 y3 years | -1246.2% | - | - |
| 5 y5 years | -325.3% | - | - |
IPHA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.7% | ||||
| 5 y | 5-year | -183.0% | +87.7% | ||||
| alltime | all time | -151.9% | +87.7% |
Innate Pharma SA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$7.50 M(-87.7%) | - | - |
| Dec 2022 | -$60.83 M(+13.8%) | - | - |
| Dec 2021 | -$53.44 M(+9489.0%) | - | - |
| Apr 2021 | - | $51.40 M(+6.7%) | $227.82 M(+2.3%) |
| Jan 2021 | - | $48.16 M(-21.8%) | $222.74 M(+7.2%) |
| Dec 2020 | -$557.30 K(-106.2%) | - | - |
| Oct 2020 | - | $61.59 M(-7.6%) | $207.79 M(+10.6%) |
| July 2020 | - | $66.67 M(+44.0%) | $187.84 M(+13.3%) |
| Apr 2020 | - | $46.31 M(+39.4%) | $165.75 M(+10.6%) |
| Jan 2020 | - | $33.21 M(-20.2%) | $149.91 M(+0.6%) |
| Dec 2019 | $9.04 M(+171.4%) | - | - |
| Oct 2019 | - | $41.64 M(-6.6%) | $148.95 M(-7.3%) |
| July 2019 | - | $44.58 M(+46.3%) | $160.65 M(-10.7%) |
| Apr 2019 | - | $30.48 M(-5.5%) | $179.94 M(+20.4%) |
| Jan 2019 | - | $32.25 M | $149.46 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $3.33 M(-106.1%) | - | - |
| Oct 2018 | - | $53.34 M(-16.5%) | $117.20 M(+83.5%) |
| July 2018 | - | $63.86 M | $63.86 M |
| Dec 2017 | -$54.25 M(-475.2%) | - | - |
| Dec 2016 | $14.46 M(-298.4%) | - | - |
| Dec 2015 | -$7.29 M(-71.9%) | - | - |
| Dec 2014 | -$25.91 M(+623.0%) | - | - |
| Dec 2013 | -$3.58 M(-6.3%) | - | - |
| Dec 2012 | -$3.82 M(-59.2%) | - | - |
| Dec 2011 | -$9.37 M(-46.2%) | - | - |
| Dec 2010 | -$17.43 M(-19.5%) | - | - |
| Dec 2009 | -$21.66 M(+13.4%) | - | - |
| Dec 2008 | -$19.10 M(+53.3%) | - | - |
| Dec 2007 | -$12.46 M(+37.0%) | - | - |
| Dec 2006 | -$9.10 M(+14.0%) | - | - |
| Dec 2005 | -$7.98 M | - | - |
FAQ
- What is Innate Pharma SA annual earnings before interest & taxes?
- What is the all time high annual EBIT for Innate Pharma SA?
- What is Innate Pharma SA annual EBIT year-on-year change?
- What is the all time high quarterly EBIT for Innate Pharma SA?
- What is the all time high TTM EBIT for Innate Pharma SA?
What is Innate Pharma SA annual earnings before interest & taxes?
The current annual EBIT of IPHA is -$7.50 M
What is the all time high annual EBIT for Innate Pharma SA?
Innate Pharma SA all-time high annual earnings before interest & taxes is $64.31 M
What is Innate Pharma SA annual EBIT year-on-year change?
Over the past year, IPHA annual earnings before interest & taxes has changed by +$53.33 M (+87.67%)
What is the all time high quarterly EBIT for Innate Pharma SA?
Innate Pharma SA all-time high quarterly earnings before interest & taxes is $66.67 M
What is the all time high TTM EBIT for Innate Pharma SA?
Innate Pharma SA all-time high TTM earnings before interest & taxes is $227.82 M